AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
NDC 45802-066, azelastine hydrochloride, fluticasone propionate, spray, metered, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-066
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208111
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-066 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZELASTINE HYDROCHLORIDE137 ug/1
- FLUTICASONE PROPIONATE50 ug/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-066-01 | 45802006601 | 1 BOTTLE in 1 CARTON (45802-066-01) / 120 SPRAY, METERED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/625ffdd0-8486-49af-8e77-6aa663be5ac7NADAC price for package 45802006601
GET /v1/drugs/nadac/45802006601
Use it
Look up 45802-066 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-066 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-066. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.